Carlsberg AS Earnings Calls
| Release date | Aug 19, 2026 |
| EPS estimate | $4.73 |
| EPS actual | - |
| Revenue estimate | 7.181B |
| Revenue actual | - |
| Expected change | +/- 2.22% |
| Release date | Feb 04, 2026 |
| EPS estimate | $4.28 |
| EPS actual | $3.09 |
| EPS Surprise | -27.80% |
| Revenue estimate | 6.784B |
| Revenue actual | 6.784B |
| Revenue Surprise | -0.0020% |
| Release date | Feb 04, 2026 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Release date | Jun 30, 2025 |
| EPS estimate | $4.61 |
| EPS actual | $4.25 |
| EPS Surprise | -7.81% |
| Revenue estimate | 7.353B |
| Revenue actual | 7.235B |
| Revenue Surprise | -1.61% |
Last 4 Quarters for Carlsberg AS
Below you can see how CABJF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jun 30, 2025 |
| Price on release | $140.00 |
| EPS estimate | $4.61 |
| EPS actual | $4.25 |
| EPS surprise | -7.81% |
| Date | Price |
|---|---|
| Jun 24, 2025 | $139.69 |
| Jun 25, 2025 | $139.44 |
| Jun 26, 2025 | $136.75 |
| Jun 27, 2025 | $139.50 |
| Jun 30, 2025 | $140.00 |
| Jul 01, 2025 | $140.00 |
| Jul 02, 2025 | $140.00 |
| Jul 03, 2025 | $140.00 |
| Jul 07, 2025 | $142.68 |
| 4 days before | 0.224% |
| 4 days after | 1.91% |
| On release day | 0% |
| Change in period | 2.14% |
| Release date | Feb 04, 2026 |
| Price on release | $131.10 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Jan 29, 2026 | $131.10 |
| Jan 30, 2026 | $131.10 |
| Feb 02, 2026 | $131.10 |
| Feb 03, 2026 | $131.10 |
| Feb 04, 2026 | $131.10 |
| Feb 05, 2026 | $131.10 |
| Feb 06, 2026 | $131.10 |
| Feb 09, 2026 | $131.10 |
| Feb 10, 2026 | $131.10 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
| Release date | Feb 04, 2026 |
| Price on release | $131.10 |
| EPS estimate | $4.28 |
| EPS actual | $3.09 |
| EPS surprise | -27.80% |
| Date | Price |
|---|---|
| Jan 29, 2026 | $131.10 |
| Jan 30, 2026 | $131.10 |
| Feb 02, 2026 | $131.10 |
| Feb 03, 2026 | $131.10 |
| Feb 04, 2026 | $131.10 |
| Feb 05, 2026 | $131.10 |
| Feb 06, 2026 | $131.10 |
| Feb 09, 2026 | $131.10 |
| Feb 10, 2026 | $131.10 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
| Release date | Aug 19, 2026 |
| Price on release | - |
| EPS estimate | $4.73 |
| EPS actual | - |
| Date | Price |
|---|---|
| Jul 07, 2026 | $139.15 |
| Jul 08, 2026 | $139.15 |
| Jul 09, 2026 | $139.15 |
| Jul 10, 2026 | $139.15 |
| Jul 13, 2026 | $139.15 |
Carlsberg AS Earnings Call Transcript Summary of Q4 2025
Carlsberg closed the Britvic acquisition in January 2025 and integrated it quickly, delivering stronger-than-expected cost synergies (≈30% of the upgraded GBP 110m target achieved in 2025) and contributing materially to reported revenue (+18.8%), volumes (+17.7%) and operating profit (+22.7%). Management introduced Management-defined Performance Measures (MPMs) to exclude PPA-related amortization (DKK ~640m in 2025) and prepare for early adoption of IFRS 18. Organic revenue was roughly flat (-0.6%) but would have been +1.1% excluding the loss of San Miguel in the U.K.; organic operating profit grew ~5% with sequential improvement into H2. Key regional highlights: strong U.K. performance post-Britvic (Pepsi Max share gains and rapid brand momentum), mixed Asia with improving China trends (Q4 stronger; 1L can format gaining traction) and solid CEEI results with strong India performance (IPO under exploration to enhance shareholder value). Kazakhstan Pepsi license ramp adds ~1.5 p.p. to group organic volume growth in 2026. Net interest-bearing debt rose to DKK 61.6bn (3.28x EBITDA); management expects to reduce leverage to ≤2.5x by end-2027 and maintain a ~50% payout policy, proposing a DKK 29 dividend (+7%). 2026 outlook: expect subdued consumer environment, flattish COGS/hl through efficiencies, CapEx DKK 6–7bn, financial expenses (ex FX) ~DKK 2.2bn, tax ~23%, and organic operating profit MPM growth of 2–6% (guidance intentionally conservative given macro/FX uncertainty).
Sign In
Buy CABJF